Icrucumab
Icrucumab (IMC-18F1) is a humanized IgG1 monoclonal antibody targeting vascular endothelial growth factor receptor-1.Icrucumab has antitumor activity.Icrucumab has been studied in metastatic colon cancer.
Product Specifications
CAS Number
1024603-92-6
Stability
≥ 2 years
Purity
>98% (HPLC)
Molecular Formula
——
Notes
Research use only, not for human use.
Receptor
VEGFR
Available Sizes
More Discoveries
Explore Other Products
Browse additional items from our catalog
orb3181042-03 10 mg
1,3-Bis (1-adamantyl) -benzimidazolium chloride
Sign In for Pricing
View Details orb3181042-04 25 mg
1,3-Bis (1-adamantyl) -benzimidazolium chloride
Sign In for Pricing
View Details 
orb3181042-05 50 mg
1,3-Bis (1-adamantyl) -benzimidazolium chloride
Sign In for Pricing
View Details ![ZNF35 Mouse Monoclonal Antibody (HRP conjugated) [Clone ID: OTI3G9]](https://cdn.genprice.uk/products/937/6868c3d7994c49e6dc4000a7/imageurl/ta807059bm.webp)
TA807059BM 100 µL
ZNF35 Mouse Monoclonal Antibody (HRP conjugated) [Clone ID: OTI3G9]
Sign In for Pricing
View Details